GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Seikagaku Corp (TSE:4548) » Definitions » Cyclically Adjusted Revenue per Share

Seikagaku (TSE:4548) Cyclically Adjusted Revenue per Share : 円582.71 (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Seikagaku Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Seikagaku's adjusted revenue per share for the three months ended in Dec. 2023 was 円170.876. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is 円582.71 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Seikagaku's average Cyclically Adjusted Revenue Growth Rate was 3.80% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 2.60% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 1.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Seikagaku was 2.60% per year. The lowest was 0.10% per year. And the median was 1.10% per year.

As of today (2024-06-10), Seikagaku's current stock price is 円813.00. Seikagaku's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was 円582.71. Seikagaku's Cyclically Adjusted PS Ratio of today is 1.40.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Seikagaku was 4.20. The lowest was 1.26. And the median was 2.03.


Seikagaku Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Seikagaku's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Seikagaku Cyclically Adjusted Revenue per Share Chart

Seikagaku Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 520.36 523.15 519.93 538.03 564.84

Seikagaku Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 561.52 564.84 571.92 577.54 582.71

Competitive Comparison of Seikagaku's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, Seikagaku's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Seikagaku's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Seikagaku's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Seikagaku's Cyclically Adjusted PS Ratio falls into.



Seikagaku Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Seikagaku's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=170.876/106.8000*106.8000
=170.876

Current CPI (Dec. 2023) = 106.8000.

Seikagaku Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 114.284 95.700 127.540
201406 133.386 98.000 145.364
201409 117.417 98.500 127.311
201412 137.802 97.900 150.329
201503 131.098 97.900 143.016
201506 136.643 98.400 148.308
201509 144.213 98.500 156.365
201512 131.731 98.100 143.414
201603 132.471 97.900 144.514
201606 145.676 98.100 158.595
201609 120.242 98.000 131.039
201612 124.428 98.400 135.050
201703 131.808 98.100 143.497
201706 132.641 98.500 143.818
201709 141.101 98.800 152.526
201712 139.670 99.400 150.068
201803 119.674 99.200 128.843
201806 127.708 99.200 137.492
201809 124.610 99.900 133.217
201812 129.955 99.700 139.210
201903 120.523 99.700 129.106
201906 135.613 99.800 145.125
201909 140.140 100.100 149.520
201912 136.223 100.500 144.762
202003 95.753 100.300 101.958
202006 121.685 99.900 130.090
202009 113.636 99.900 121.485
202012 128.885 99.300 138.620
202103 127.308 99.900 136.101
202106 208.829 99.500 224.150
202109 154.988 100.100 165.362
202112 134.946 100.100 143.978
202203 119.216 101.100 125.937
202206 148.112 101.800 155.387
202209 161.337 103.100 167.127
202212 162.369 104.100 166.580
202303 133.707 104.400 136.781
202306 177.247 105.200 179.943
202309 153.869 106.200 154.738
202312 170.876 106.800 170.876

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Seikagaku  (TSE:4548) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Seikagaku's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=813.00/582.71
=1.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Seikagaku was 4.20. The lowest was 1.26. And the median was 2.03.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Seikagaku Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Seikagaku's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Seikagaku (TSE:4548) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Marunouchi Center Building 10 Floor, 6-1, Marunouchi 1-chome, Chiyoda-ku, Tokyo, JPN, 100-0005
Seikagaku Corp makes and sells pharmaceuticals and medical devices related to glycoconjugates. The firm operates in two segments: pharmaceutical and LAL. The pharmaceutical segment contributes the majority of revenue. This business sells pharmaceutical products made from hyaluronic acid, a major component of glycoconjugates, as well as medical devices and bulk products. The LAL segment manufactures endotoxin-detecting reagents made from limulus amebocyte lysate that are used to control quality in the pharmaceutical manufacturing process. Seikagaku generates the majority of its sales in Japan.

Seikagaku (TSE:4548) Headlines

No Headlines